June 24, 2020 / 11:33 AM / 11 days ago

BRIEF-BrainStorm Expands Clinical Pipeline To Evaluate Nurown For Treatment Of Alzheimer's Disease

June 24 (Reuters) - BrainStorm Cell Therapeutics Inc :

* BRAINSTORM EXPANDS CLINICAL PIPELINE TO EVALUATE NUROWN FOR THE TREATMENT OF ALZHEIMER’S DISEASE

* BRAINSTORM CELL THERAPEUTICS - PROTOCOL FOR PROPOSED MULTI-NATIONAL TRIAL HAS BEEN SUBMITTED FOR EU REGULATORY APPROVAL

* BRAINSTORM CELL THERAPEUTICS - PHASE 2 TRIAL TO EVALUATE SAFETY & EFFICACY OF NUROWN TREATMENT IN THOSE WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below